ELAVL1

Across TCGA pan-cancer cohorts, ELAVL1 RNA differs between tumor and matched normal tissue in 15 of 18 cancer types tested, making tumor–normal expression one of ELAVL1’s most consistent transcriptional readouts.

The strongest signal is observed in colon adenocarcinoma (COAD), where ELAVL1 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types ELAVL1 is over-expressed in tumor.

COAD, BLCA, and HNSC are the cancer types where ELAVL1 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in ELAVL1 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
COAD	Female	II,III,IV	+0.876	<.001	11	view →
BLCA	All	III,IV	+0.566	<.001	11	view →
HNSC	Male	IV	+0.977	<.001	10	view →
KIRP	All	III,IV	+0.661	<.001	10	view →
LIHC	Female	II,III,IV	+1.145	<.001	9	view →
STAD	Male	II,III,IV	+0.905	<.001	9	view →
KIRC	All	All	+0.239	<.001	9	view →
LUSC	Male	II,III,IV	+0.766	<.001	8	view →
LUAD	Male	II,III,IV	+0.469	<.001	8	view →
READ	All	III,IV	+0.939	<.001	7	view →
BRCA	All	III,IV	+0.640	<.001	6	view →
UCEC	All	II,III,IV	+0.567	.017	6	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 12 strongest of 15 lineages.

ELAVL1–COAD

Open the COAD breakdown →